Immunome Inc. (IMNM)
$27.70-$1.17 (-4.05%) Today
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 10,500 | $204K |
| Open-market sale | 20 | 692,810 | $15.88M |
| Grant or award | 20 | 1,341,132 | |
| Option exercise | 12 | 523,416 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
44 Form 4 filings on record, the earliest from Nov 25, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Jack Higgins - Officer | Option exercise | Common Stock | 22,000 | $1.35 | $30K | |
| Jack Higgins - Officer | Option exercise | Employee Stock option (right to buy) | 22,000 | $0.00 | - | |
| Kinney Horn - Officer | Grant or award | Employee Stock Option (right to buy) | 161,000 | $0.00 | - | |
 Robert Lechleider - Officer | Grant or award | Employee Stock Option (right to buy) | 242,000 | $0.00 | - | |
 Max Rosett - Officer | Grant or award | Employee Stock Option (right to buy) | 207,000 | $0.00 | - | |
| Jack Higgins - Officer | Grant or award | Employee Stock Option (right to buy) | 196,000 | $0.00 | - | |
 Sandra G. Stoneman - Officer | Grant or award | Employee Stock Option (right to buy) | 190,000 | $0.00 | - | |
| Philip Tsai - Officer | Grant or award | Employee Stock Option (right to buy) | 190,000 | $0.00 | - | |
 Clay B. Siegall - Officer | Grant or award | Employee Stock Option (right to buy) | 800,000 | $0.00 | - | |
| Jean Jacques Bienaime | Grant or award | Director Stock Option (right to buy) | 18,864 | $0.00 | - | |
| Carol Schafer | Grant or award | Director Stock Option (right to buy) | 18,864 | $0.00 | - | |
| Jean Jacques Bienaime | Open-market purchase | Common Stock | 5,000 | $9.38 | $47K | |
| Clay B. Siegall - Officer | Open-market purchase | Common Stock | 66,057 | $9.54 | $630K | |
| Clay B. Siegall - Officer | Open-market purchase | Common Stock | 33,943 | $9.78 | $332K | |
| Robert Lechleider - Officer | Open-market purchase | Common Stock | 15,805 | $9.48 | $150K | |
| Philip Tsai - Officer | Open-market purchase | Common Stock | 21,000 | $9.43 | $198K |
This is as far as the anonymous view goes. Create a free account for all 44 IMNM filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Barchas Isaac | Director | 11,048 | $301K | View on EDGAR | |
| ABHMC II, LLC | Shareholder | 108,504 | $2.77M | View on EDGAR | |
| Horn Kinney | Officer | 90,616 | $2.27M | View on EDGAR |
Immunome Inc. (IMNM) had 23 insider filings in the last 90 days, with the most recent on 2026-08-12. The full record for IMNM runs to 44 Form 4 filings, the earliest from 2024-11-25. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
3 insider purchases of IMNM were filed in the last 90 days, totaling $204K.
20 insider sales of IMNM were filed in the last 90 days, totaling $15.88M.
This page tracks IMNM Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add IMNM to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
